Liu Ning, Tang Bin, Wei Pan, Sun Wanchun, Wang Shuangxi, Peng Qisheng
Central Laboratory, The Second Hospital of Jilin University, Changchun 130041, China.
Key Laboratory for Zoonosis Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun 130062, China.
Mol Immunol. 2015 Dec;68(2 Pt C):699-705. doi: 10.1016/j.molimm.2015.10.021. Epub 2015 Nov 6.
Our previous study showed that the downstream of kinase 3 (DOK3) is degraded during macrophage stimulation with CpG. However, the underlying mechanism and role in Toll-like receptor 9 (TLR9) signaling remains elusive. In this study, we demonstrate that CpG treatment leads to ubiquitin-mediated degradation of DOK3 via interaction with an E3 ligase TNFR-associated factor 6 (TRAF6). We also identified the 27th amino acid (lysine) of DOK3 is responsible for Ly48 polyubiquitination of DOK3. Furthermore, reintroduction of DOK3 (K27R) into DOK3-deficient macrophages abolishes DOK3 degradation induced by CpG and suppresses the production of IL-6 and TNFα. More importantly, our study uncovers a novel role of an E3 ligase TRAF6, namely, TRAF6 is also able to catalyse Lys 48 polyubiquitylation of target protein except for Lys 63 polyubiquitylation.
我们之前的研究表明,在用CpG刺激巨噬细胞的过程中,激酶3下游分子(DOK3)会发生降解。然而,其潜在机制以及在Toll样受体9(TLR9)信号传导中的作用仍不清楚。在本研究中,我们证明CpG处理通过与E3连接酶肿瘤坏死因子受体相关因子6(TRAF6)相互作用,导致DOK3经泛素介导的降解。我们还确定DOK3的第27位氨基酸(赖氨酸)负责DOK3的Ly48多聚泛素化。此外,将DOK3(K27R)重新导入DOK3缺陷型巨噬细胞中可消除CpG诱导的DOK3降解,并抑制白细胞介素-6(IL-6)和肿瘤坏死因子α(TNFα)的产生。更重要的是,我们的研究揭示了E3连接酶TRAF6的一个新作用,即TRAF6除了能够催化靶蛋白的Lys63多聚泛素化外,还能够催化其Lys48多聚泛素化。